Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Añadir filtros








Intervalo de año
1.
Tropical Biomedicine ; : 452-457, 2020.
Artículo en Inglés | WPRIM | ID: wpr-823227

RESUMEN

@# Toxoplasma gondii is a world-widely spread zoonotic parasite. However, scarce knowledge is known about the prevalence of T. gondii infection in people in Hubei province, China. This study herein was to perform epidemiological investigation of T. gondii infection in people in this region. A total 12527 blood samples were obtained during 2015-2018, and were assayed for T. gondii antibodies of IgG and IgM, respectively by employing an indirect hemagglutination test (IHA). The results discovered that the prevalence of T. gondii in people was 2.44% and 6.1%, respectively based on antibodies of IgG and IgM, respectively. The prevalence was ranged from 0.3% to 5.4% during 2015-2018 based on IgM antibodies. For genders, the prevalence was 0.7% and 2.6% in males and females, respectively based on IgM antibodies. In different years, the prevalence was ranged from 4.9% to 14.0% based on IgG antibodies. The prevalence of T. gondii was 4.9% and 6.6% in males and femalesy based on IgG antibodies. The current results may be helpful for the implementation of preventive measures against Toxoplasma infection among people living in this region.

2.
Artículo en Inglés | IMSEAR | ID: sea-178261

RESUMEN

To explain the effectiveness of different oral and intravenous (IV) Proton Pump Inhibitors (PPI) used in the management of peptic ulcer re-bleeding after successful endoscopic intervention. This article offers the summarization of various articles on PPI which are published in a well-known journals. All the articles used the same method in the management of peptic ulcer re-bleeding. Rockall risk scoring system were used for grading the rate of the bleeding. Pubmed and Embase was used to identify the related articles that assessed the efficacy of PPI and found Six articles matched our criteria. All the results where P <0.05 where considered significant for writing this review article. Neither any alterations or modifications nor any softwares were used in this article. All the results and conclusions were briefed and summarized carefully after a through discussion of the articles included in our review.

3.
Braz. j. med. biol. res ; 47(3): 237-244, 03/2014. tab, graf
Artículo en Inglés | LILACS | ID: lil-704626

RESUMEN

Studies have indicated that early-life or early-onset depression is associated with a 2- to 4-fold increased risk of developing Alzheimers disease (AD). In AD, aggregation of an abnormally phosphorylated form of the tau protein may be a key pathological event. Tau is known to play a major role in promoting microtubule assembly and stabilization, and in maintaining the normal morphology of neurons. Several studies have reported that stress may induce tau phosphorylation. The main aim of the present study was to investigate possible alterations in the tau protein in the hippocampus and frontal cortex of 32 male Sprague-Dawley rats exposed to chronic unpredictable mild stress (CUMS) and then re-exposed to CUMS to mimic depression and the recurrence of depression, respectively, in humans. We evaluated the effects of CUMS, fluoxetine, and CUMS re-exposure on tau and phospho-tau. Our results showed that a single exposure to CUMS caused a significant reduction in sucrose preference, indicating a state of anhedonia. The change in behavior was accompanied by specific alterations in phospho-tau protein levels, but fluoxetine treatment reversed the CUMS-induced impairments. Moreover, changes in sucrose preference and phospho-tau were more pronounced in rats re-exposed to CUMS than in those subjected to a single exposure. Our results suggest that changes in tau phosphorylation may contribute to the link between depression and AD.


Asunto(s)
Animales , Masculino , Depresión/metabolismo , Lóbulo Frontal/metabolismo , Hipocampo/metabolismo , Estrés Psicológico/metabolismo , Proteínas tau/metabolismo , Análisis de Varianza , Anhedonia , Enfermedad de Alzheimer/complicaciones , Antidepresivos de Segunda Generación/uso terapéutico , Depresión/complicaciones , Depresión/tratamiento farmacológico , Fluoxetina/uso terapéutico , Preferencias Alimentarias/psicología , Fosforilación , Ratas Sprague-Dawley , Estrés Psicológico/complicaciones , Estrés Psicológico/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA